Stran & Company Reports 32% Increase in Third Quarter 2026 Gross Profit as Gross Margin Expands to 33.3%

Stran & Company, Inc. (SWAG) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Stran & Company Reports 32% Increase in Third Quarter 2026 Gross Profit as Gross Margin Expands to 33.3% Nine-Month Net Income of $1.1 Million, an Improvement of $2.1 Million Over the Prior-Year Period Conference Call to be Held Wednesday, November 11, 2026 at 10:00

Original reporting
Published Nov 10, 2026, 9:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 10, 2026, 9:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$SWAG
Bullish
high confidence
Mentioned
$SWAG
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$SWAGBullishMed
01

Why it matters

The earnings release shows a turnaround from loss to profit, margin expansion, and a modest share buyback, which could prompt short‑term buying interest.

02

Market read

First‑report earnings for a micro‑cap; modest but positive surprise may generate short‑term price movement.

03

What to watch

Share repurchase of 109,000 shares could dilute future upside if earnings growth stalls.

Relevance 7/10Novelty 7/10Timing: today

Background

Stran & Company is a NASDAQ‑listed provider of promotional products and loyalty solutions. The 8‑K filing reports its Q3 and nine‑month financials for 2026.

Company-level read

Ticker impact

$SWAGBullishHigh confidence
Context

Stran & Company disclosed Q3 2026 results with 32% gross profit growth, margin expansion to 33.3% and a swing to net income.

Expected impact

likely upward pressure as investors price in stronger margins and profitability

Evidence & confidence

The company turned a $1.2M loss into $35K profit and improved EBITDA, indicating operational turnaround that can attract buying.

Market effects

Positive earnings may lift the promotional products and loyalty solutions niche.

Limited to U.S. small‑cap investors; no broader regional effect.

Minimal; the company is a micro‑cap with niche exposure.

Counterpoint

The profit improvement is modest in absolute terms; the company remains cash‑flow constrained and may face execution risk.

Key entities

  • Stran & Company

    NASDAQ‑listed promotional products and loyalty solutions provider.

  • Andy Shape

    Chief Executive Officer of Stran & Company.

Related articles

$SWAGMed

Stran (SWAG) Q2 2026 Earnings Call Transcript

Stran (SWAG) reported Q2 2026 revenue of $33.4M, up 2.4% YoY. Stran segment revenue grew 6.9% YoY, while SLS segment revenue declined 6.5%. Gross profit increased 1.6% to $10.0M, with gross margin at 30.0%. Net income was $309K, down from $643K YoY. The company secured new contracts and improved SLS gross margin to 24.3%. Management expects public warrant expiration in Q4 2026.

$SWAGMed

Stran & Company Reports $33.4 Million in Revenue and $0.6 Million in EBITDA for the Second Quarter of 2026

Stran & Company, Inc. (SWAG) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Stran & Company Reports $33.4 Million in Revenue and $0.6 Million in EBITDA for the Second Quarter of 2026 Conference Call to be Held Wednesday, August 12, 2026 at 10:00 a.m. Eastern Time Quincy, MA / August 11, 2026 / Stran & Company, Inc. (“Stran” or the “Company”)

$AZTAMedAI 8/10

Azenta Reports Fourth Quarter and Full Year Results for Fiscal 2026, Ended September 30, 2026

Azenta, Inc. (AZTA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Azenta Reports Fourth Quarter and Full Year Results for Fiscal 2026, Ended September 30, 2026. • Q4'26 reported revenue growth of 5% year over year and 2% on an organic basis • FY'26 reported revenue growth of 5% year over year and 2% on an organic basis • FY'27 repo

$HYLNMed

HYLIION HOLDINGS REPORTS THIRD-QUARTER 2026 FINANCIAL RESULTS

Hyliion Holdings Corp. (HYLN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 HYLIION HOLDINGS REPORTS THIRD-QUARTER 2026 FINANCIAL RESULTS AUSTIN, Texas, November 10, 2026 – Hyliion Holdings Corp. (NYSE American: HYLN) (“Hyliion”), a developer of modular power plant technology, today reported financial results for the third quarter ended Sept

$INMMedAI 8/10

InMed Pharmaceuticals Inc. (INM): UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

InMed Pharmaceuticals Inc. (INM) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Defined terms included below shall have the same meaning as terms defined and included in the Company’s definitive proxy statement/prospectus filed with the U.S. Securities and Exchange Commission (the “SEC

$TLFMed

Tandy Leather Factory Reports Third Quarter 2026 Results

TANDY LEATHER FACTORY INC (TLF) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE November 10, 2026 Tandy Leather Factory Reports Third Quarter 2026 Results BENBROOK, TEXAS – November 10, 2026 (GLOBE NEWSWIRE) – Tandy Leather Factory, Inc. (Nasdaq: TLF) today announced the Company’s financial results for the third fiscal quar